Silence Therapeutics plc (SLN)

NASDAQ: SLN · Real-Time Price · USD

5.77

-0.46 (-7.38%)

At close: May 19, 2026, 4:00 PM EDT

5.68

-0.09 (-1.52%)

After-hours: May 19, 2026, 7:28 PM EDT

Silence Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.66	11.28	121.33	68.79	66.32	99.42
Short-Term Investments	64.42	73.84	26	-	19.75	-
Cash & Short-Term Investments	70.08	85.11	147.33	68.79	86.07	99.42
Cash Growth	-48.67%	-42.23%	114.18%	-20.08%	-13.43%	86.74%
Accounts Receivable	-	-	0.97	0.29	1.11	0.45
Other Receivables	22.22	22.01	24.4	22.44	18	9.39
Total Trade Receivables	22.22	22.01	25.37	22.73	19.11	9.84
Other Current Assets	10.56	11.54	14.66	11.63	11.79	7.46
Total Current Assets	102.85	118.66	187.37	103.15	116.97	116.72
Net Property, Plant & Equipment	1.54	1.75	1.98	2.31	2.66	2.63
Other Intangible Assets	0.25	0.29	0.31	0.36	0.39	0.03
Goodwill	10.36	10.62	9.39	9.98	9.69	10.26
Long-Term Investments	-	-	-	-	0.34	0.41
Other Long-Term Assets	0.13	0.13	3.59	3.65	-	-
Total Assets	115.12	131.44	202.64	119.45	130.05	130.05
Accounts Payable	10.37	13.36	16.4	15.54	15.28	14.58
Current Portion of Leases	0.09	0.09	0.12	0.23	0.54	0.19
Unearned Revenue	-	0.17	0.31	6.57	10.72	5.74
Total Current Liabilities	10.46	13.61	16.82	22.34	26.55	20.51
Long-Term Leases	0.04	0.07	-	0.12	-	-
Other Long-Term Liabilities	55.22	55.45	51.79	75	-	-
Total Long-Term Liabilities	55.26	55.53	51.79	75.12	-	-
Total Liabilities	65.72	69.14	68.61	97.46	26.55	20.51
Common Stock	-10.29	-10.29	-10.29	-8.85	6.52	6.07
Additional Paid-in Capital	-620.01	-617.56	-609.56	-455.77	336.16	304.82
Accumulated Other Comprehensive Income	3.37	2.98	11.78	10.73	-	-
Retained Earnings	577.53	562.57	474.04	431.89	-318.5	-301.45
Shareholders' Equity	-49.4	-62.3	-134.02	-21.99	26.7	11.53
Total Liabilities & Equity	115.12	131.44	202.64	119.45	53.25	32.03
Total Debt	0.14	0.16	0.12	0.35	0.54	0.19
Net Cash (Debt)	69.94	84.95	147.22	68.44	85.53	99.24
Net Cash Growth	-17.67%	-42.29%	115.09%	-19.98%	-13.81%	88.04%
Net Cash Per Share	1.48	1.80	3.18	1.84	2.66	3.35
Book Value	-49.4	-62.3	-134.02	-21.99	26.7	11.53
Book Value Per Share	-1.05	-1.32	-2.90	-0.59	0.83	0.39
Tangible Book Value	-60.01	-73.21	-143.73	-32.34	16.63	1.23
Tangible Book Value Per Share	-1.27	-1.55	-3.11	-0.87	0.52	0.04

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q